- Dosages
- Side effects in children
- Warnings & precautions in children
- Contra-indications in children
-
Interactions - PK
- Renal impairment
- References
Pharmacokinetics in children
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
dose recommendation of formulary compared to licensed use (on-label versus off-label)
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Available formulations
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Dosages
| Various rheumatological, pulmonary, gastrointestinal, haematological, nephrological, endocrinological, oncological, neurological, ocular and dermatological disorders, as well as severe allergic reactions, organ transplantation and prophylaxis of nausea and vomiting due to high-emetogenic chemotherapy |
|---|
|
| Laryngitis subglottica (pseudo-croup) |
|---|
|
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Renal impaiment in children > 3 months
No information available on dose adjustment in renal impairment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions in children
There is a preference for the use of prednisolone over prednisone due to the (rare) occurrence of a conversion defect (11-beta-hydroxysteroid dehydrogenase reductase ectivity).
Closely monitor growth and development of children with long-term use; to avoid growth inhibition, aim for alternating doses.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
| Mineralocorticoids | ||
|---|---|---|
| H02AA02 | ||
| Glucocorticoids | ||
|---|---|---|
| H02AB02 | ||
| H02AB09 | ||
| H02AB04 | ||
| H02AB06 | ||
| H02AB08 | ||
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
References
- Trommsdorff GmbH & Co., SmPC Rectodelt® 100 mg, Zäpfchen (6329964.00.00), 06/2021
- GALENpharma GmbH, SmPC Prednison 5/10/20/50 mg GALEN® Tabletten (33644.00.00), 03/2021
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Changes
Changes
